Ocuphire Pharma Announces Financial Results for Fourth Quarter and Year Ended 2022 and Provides Corporate Update
Wall Street Online Denmark,
FARMINGTON HILLS, Mich., March 30, 2023 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc.
FARMINGTON HILLS, Mich., March 30, 2023 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc.
Financial Profile Improved Markedly with Global License Agreement to Develop and Commercialize Nyxol for All Three Indications…
Financial Profile Improved Markedly with Global License Agreement to Develop and Commercialize Nyxol for All Three Indications…